Keyword: Coronavirus

News

Trials Show Comirnaty Safe for Children 5 to 11

21.09.2021 -

Phase 2/3 clinical trials with the Pfizer/BioNTech Covid-19 vaccine Comirnaty have shown that it is safe, well tolerated and produces robust neutralizing antibody...

News

CureVac Cancels two Vaccine Manufacture Deals

15.09.2021 -

German biotech CureVac has canceled manufacturing contracts with two prospective partners for its Covid-19 vaccine CVnCoV while retaining others. The company said on Sept...

News

FDA Grants BioNTech Full Approval for Covid Vaccine

24.08.2021 -

First to receive US approval under an Emergency Use Authorization (EUA) in late 2020, the BioNTech/Pfizer Covid-19 vaccine on Aug. 23 became the first to be fully...

News

CDC Nods off on Covid Shot Boosters for Vulnerable

16.08.2021 -

As the delta variant of the coronavirus tears through the US, pushing both new and breakthrough infections higher, the US Centers for Disease Control (CDC) has now come...

News

Novavax Again Delays EUA Filing with FDA

12.08.2021 -

As it continues to grapple with documentation issues, US biotech Novavax has again altered its timeline for seeking Emergency Use Authorization (EUA) from the US Food and...

News

FDA Speeds up Full Approval Process for Comirnaty

11.08.2021 -

Pfizer and BioNTech applied to the US Food and Drug Administration (FDA) in May for full authorization of their Covid-19 vaccine Comirnaty, and in the interest of...

News

Biovac to Produce Comirnaty in South Africa

23.07.2021 -

As part of a new supply chain partnership, South Africa’s Biovac will produce Pfizer and BioNTech’s Comirnaty-branded Covid-19 vaccine at its Capetown site from the end...

News

Final Tally of CureVac Covid Candidate Confirms 48% Efficacy

02.07.2021 -

Definitive results from CureVac’s 40,000-subject international Phase 2b/3 trial with its mRNA-based Covid-19 vaccine candidate, CVnCoV, have confirmed an earlier finding...